OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sorafenib-Based Drug Delivery Systems: Applications and Perspectives
Lingyun Wang, Meihuan Chen, Xueguang Ran, et al.
Polymers (2023) Vol. 15, Iss. 12, pp. 2638-2638
Open Access | Times Cited: 9

Showing 9 citing articles:

Biomaterial-Based Responsive Nanomedicines for Targeting Solid Tumor Microenvironments
Konstantinos Avgoustakis, Athina Angelopoulou
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 179-179
Open Access | Times Cited: 6

Understanding Sorafenib-Induced Cardiovascular Toxicity: Mechanisms and Treatment Implications
Jue Li, Lusha Zhang, Teng Ge, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 829-843
Open Access | Times Cited: 6

In vitro cytotoxicity of magnetic-fluorescent bioactive glasses on SaOS-2, MC3T3-E1, BJ fibroblast cells, their hemolytic activity, and sorafenib release behavior
Aylin M. Deliormanlı, Begüm Rahman, Harika Atmaca
Biomaterials Advances (2024) Vol. 158, pp. 213782-213782
Closed Access | Times Cited: 1

Study on synthesizing the complex of sorafenib with 2-hydroxypropyl-β-cyclodextrin to enhance the anticancer activity of the drug substance
Van Cuong Bui, Phạm Thị Lan, Thi Lam Nguyen, et al.
Pure and Applied Chemistry (2024) Vol. 96, Iss. 8, pp. 1091-1099
Closed Access

Preparation of Glutathione-Regulated Sorafenib Targeted Nanodrug Delivery System and Its Antihepatocellular Carcinoma Activity
Yijun Wu, Xiaochen Wang, Longxia Li, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 47, pp. 65131-65141
Closed Access

A real-world pharmacovigilance study of Sorafenib based on the FDA Adverse Event Reporting System
Dongdong Zhang, Ying Cai, Yixin Sun, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access

Bibliometric study on the utilization of sorafenib in hepatocellular carcinoma
Wenjun Meng, Yihang Luo, Zhao Lu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access

Page 1

Scroll to top